Article

A Super-Potent Tetramerized ACE2 Protein Displays Enhanced Neutralization of SARS-CoV-2 Virus Infection

2021-02-08

Abstract excerpt

Approaches are needed for therapy of the severe acute respiratory syndrome from SARS-CoV-2 coronavirus (COVID-19). Interfering with the interaction of viral antigens with the angiotensin converting enzyme 2 (ACE-2) receptor is a promising strategy by blocking the infection of the coronaviruses into human cells. We have implemented a novel protein engineering technology to produce a super-potent tetravalent form of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bf56a198-956d-59df-95ea-01769c602b40
DOI: 10.21203/rs.3.rs-151560/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Super-Potent Tetramerized ACE2 Protein Displays Enhanced Neutralization of SARS-CoV-2 Virus InfectionDOI 10.21203/rs.3.rs-151560/v1Read

A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency.Semantic proximity Read

Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.Semantic proximity Read

ACE2-based decoy receptors for SARS coronavirus 2.Semantic proximity Read

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activitiesSemantic proximity Read

A recombinant ‘ACE2 Triple Decoy’ that traps and neutralizes SARS-CoV-2 shows enhanced affinity for highly transmissible SARS-CoV-2 variantsSemantic proximity Read

High affinity modified ACE2 receptors protect from SARS-CoV-2 infection in hamstersSemantic proximity Read

Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo.Semantic proximity Read

Broadly effective ACE2 decoy proteins protect mice from lethal SARS-CoV-2 infectionSemantic proximity Read

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants.Semantic proximity Read

David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitorsSemantic proximity Read

Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection.Semantic proximity Read

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.Semantic proximity Read